BioMarin to Participate in Two Investor Conferences in October
SAN RAFAEL, Calif., Sept. 19, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in two investor conferences this October. To access the events that are accessible by live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.
About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.
For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.
According to data from the CDC, the construction industry has the highest overdose death rate across all industries1. Construction workers are five times more likely to die by suicide than safety-related issues2. BTEA is uniting the union...
A2 Biotherapeutics, Inc. (A2 Bio) a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to selectively target tumor cells and protect normal cells, today announced the acceptance of three posters for presentation...
Qualitas Dental Partners proudly announces its partnership with the foremost oral surgery group in New England, furthering its commitment to deliver patient-centric dental care across the region....
MAKO Medical, a leader in healthcare diagnostics and laboratory services, is honored to announce its partnership with Rebuilding Together, a renowned nonprofit organization focused on repairing homes, revitalizing communities, and rebuilding lives....
Antibe Therapeutics Inc. ("Antibe" or the "Company") announced that the Company's request for an extension of its previously announced stay of proceedings under the Companies' Creditors Arrangement Act (the "CCAA") was heard before the Ontario...
The Human Animal Bond Research Institute (HABRI) today announced a new grant for research that investigates the contribution of pet dog ownership to resilience and well-being in adolescent children of military families. This grant was awarded to a...
